Predicting Providing Substantial Evidence of Clinical Benefit for New Drug Approvals Albert Deisseroth, Division of Hematology Products February 27, 2013 - Idiopathic CD4 lymphocytopenia - Document - PDFSEARCH.IO

First Page	Meta Content
	Predicting/Providing Substantial Evidence of Clinical Benefit for New Drug Approvals Albert Deisseroth, Division of Hematology Products February 27, 2013 Add to Reading List Open Document File Size: 95,44 KB Share Result on Facebook Company Surrogate Marker Working Group / / Currency pence / / MedicalCondition HIV / opportunistic infections / HIV RNA / / Organization Division of Hematology Products / FDA / National Institute of Health / / SocialTag Research Viral load Surrogate endpoint HIV FDA Fast Track Development Program Clinical endpoint Food and Drug Administration Imaging biomarker Discovery and development of integrase inhibitors Medicine

Predicting/Providing Substantial Evidence of Clinical Benefit for New Drug Approvals Albert Deisseroth, Division of Hematology Products February 27, 2013Add to Reading List